Company: INDP
Filing Date: 2025-06-23
Form Type: DEF 14A
Source: 0001641172-25-016071
Chunk: 18

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-23
Form: DEF 14A
Chunk 18
---
                        |

| (4) | Consists of (i) 1,212,837 shares of common                                                          
 stock, and (ii) 1,135,761 shares of common stock issuable upon exercise of warrants which           
 are subject to either a 4.99% or 9.99% beneficial ownership limitation. The amounts and percentages 
 in the table do not give effect to such beneficial ownership limitation.                            |

| (5) | Consists of (i) 1,341,524 shares of common                                                     
 stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee; 
 (ii) 26,832 shares of common stock held by Janet Lee Harris, Trustee of the Janet Harris       
 Living Trust, executed on March 25, 2009. Ms. Harris is the spouse of Dr. Newman, and as       
 such, Dr. Newman is deemed to beneficially own such shares; and (iii) 391,017 shares of common 
 stock issuable upon exercise of outstanding options, of which 7,208 will vest within 60 days   
 of June 12, 2025.                                                                              |

| (6) | Consists of (i) 202,859 shares of common                                                        
 stock, (ii) 127,485 shares of common stock issuable upon exercise of warrants, and (ii) 708,333 
 shares of common stock issuable upon exercise of outstanding options, of which 16,667 will      
 vest within 60 days of June 12, 2025.                                                           |

| (7) | Consists of 97,500 shares of common stock issuable upon exercise                   
 of outstanding options, of which 13,750 will vest within 60 days of June 12, 2025. |

| (8) | Consists of (i) 150 shares of common stock and (ii) 326,683 shares                             
 of common stock issuable upon exercise of outstanding options, of which 9,583 will vest within 
 60 days of June 12, 2025.                                                                      |

| (9) | Consists of 52,500 shares of common stock issuable upon exercise 
 of outstanding options.                                          |

| (10) | Consists of (i) 670 shares of common stock and (ii) 52,500 shares 
 of common stock issuable upon exercise of outstanding options.    |

| (